Pretomanid
Sold as Pretomanid viatris, Mypreto, Pretamyl, Maknid, Pretomanid macleods, Pretomanid PD
(6S)-2-Nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine
Drag to rotate. Structure from PubChem CID 456199.
Background
Registration
- Applicants
- 3
- Registrations
- 6
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Viatris Healthcare (Pty) LtdCertificate held by Mylan (Pty) Ltd | Pretomanid viatris, Mypreto, Pretamyl | 200 mg | 540655, 540656.655, 540657.655 | S4 | PIPIL |
| Macleods Pharmaceuticals SA (Pty) Ltd | Maknid, Pretomanid macleods | 200 mg | 570626, 570627.626 | S4 | None |
| Pharma Dynamics (Pty) Ltd | Pretomanid PD | 200 mg | 590521 | S4 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Pretomanid viatris EACH TABLET CONTAINS PRETOMANID 200,0 mg | Not listed | 54065554/20.2.3/0655 | Registered | S4 | None |
| Mypreto EACH TABLET CONTAINS PRETOMANID 200,0 mg | 200 mgTablets | 540656.65554/20.2.3/0656.655Approved 30 May 2023 | Registered | S4 | PIPIL |
| Pretamyl EACH TABLET CONTAINS PRETOMANID 200,0 mg | 200 mgTablets | 540657.65554/20.2.3/0657.655Approved 30 May 2023 | Registered | S4 | PIPIL |
| Maknid 200 MG EACH TABLET CONTAINS:PRETOMANID 200,0 mg | 200 mg | 57062657/20.2.3/0626 | Registered | S4 | None |
| Pretomanid 200 MG macleods EACH TABLET CONTAINS PRETOMANID 200,0 mg | 200 mg | 570627.62657/20.2.3/0627.626 | Registered | S4 | None |
| Pretomanid 200 MG PD EACH TABLET CONTAINS: PRETOMANID 200,0 mg | 200 mg | 59052159/20.2.3/0521 | Registered | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Pretomanid
S4: Pretomanid
Consolidated Schedules 06 July 2026, line 7637
Pharmacological class: Tuberculostatics. (class 20.2.3)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.